@chanceofrain__ Huh? This is one meta-analysis pretty well-cited (incl. by CDC FWIW). https://t.co/RsGZa0ztx1 https://t.co/YSO4mES5eV
RT @IDAdvance: International Journal of Infectious Diseases #MostCited article - https://t.co/rHElvkarLZ. @ISID_org #COVID19
International Journal of Infectious Diseases #MostCited article - https://t.co/rHElvkarLZ. @ISID_org #COVID19
RT @IDAdvance: Top download from IJID assessed the prevalence of comorbidities in the #COVID19 patients & found underlying #Disease, inc. #…
Top download from IJID assessed the prevalence of comorbidities in the #COVID19 patients & found underlying #Disease, inc. #Hypertension, #Respiratory system disease & #Cardiovascular disease, may be risk factors for severe patients: https://t.co/r
@Dylan_Housman @DailyCaller @ShelbyTalcott I've known all the data since March ... they've known the data since at least January Everything: symptoms, stratified age risk, most at risk comorbidities, etc... Yet they have done nothing aside operation warp
@BallouxFrancois Yup ... here's a study from March 2020 that shows morbidities, and links 7 studies that also cover this, including age groups https://t.co/kiL81nXc9F
RT @itechnologynet: @MaizyDaizyZzzz Did some quick google magic March 2020, and even links a study in the lancet from January 2020 Just b…
RT @itechnologynet: @MaizyDaizyZzzz Did some quick google magic March 2020, and even links a study in the lancet from January 2020 Just b…
@MaizyDaizyZzzz Did some quick google magic March 2020, and even links a study in the lancet from January 2020 Just back then ppl were like ..yeah, china, too early, whatever https://t.co/s943uXeA2c
Sources: Figliozzi et al., 2020: https://t.co/JaYGkYAd2i Lin et al., 2020: https://t.co/YEjYbXHuEP Yang et al., 2020: https://t.co/1jpyEw9AJ9 Xu et al., 2020: https://t.co/KVhjxjnH5H Chidambaram et al., 2020: https://t.co/HZqVLm17dc
"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis", most cited article from International Journal of Infectious Diseases available now: https://t.co/rHElvkarLZ. @ProMED_mail @ISID_org
@kiwiinOC @BarryCrocker13 @matteastnz @5amHill @Rachel_Smalley No need for new research. Just that your interpretation and understanding of comorbidities is flawed. As I already mentioned, they’re risk factors, not causes. Read this: https://t.co/GXPS24XAL
@Churchill_99 @Swisher3333 @looking5452 @GeorJWashington @NBCNewYork Flash quiz: 1. What Percentage of SARS-CoV-2 deaths don't have comorbidities? 2. What is the average number of comorbidities for SARS-CoV-2 deaths? https://t.co/kYM94vClyG
Surprisingly, respiratory system disease is one of the least prevalent comorbidities of COVID. It's actually very alarming how many organs this virus can seriously affect. #Pandemic #NovelCoronavirus https://t.co/duFjs5wxeQ
nih kalo ga percaya gw selipin risetnya: - https://t.co/WzFPgyVWFF - https://t.co/dqxiCYa8vt
RT @ale_giseli: #COVID19 Prevalência de comorbidades e seus efeitos em pacientes infectados com SARS-CoV-2: revisão sistemática e metanális…
#COVID19 Prevalência de comorbidades e seus efeitos em pacientes infectados com SARS-CoV-2: revisão sistemática e metanálise https://t.co/06sMHpkwjz
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
RT @QuantumGenomics: This meta-analysis shows that #Hypertension is by far the most important co-morbidity factor in #Covid19 patients, hen…
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
RT @QuantumGenomics: Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patient…
This meta-analysis shows that #Hypertension is by far the most important co-morbidity factor in #Covid19 patients, hence the need for new treatments such as #Firibastat. #QuantumGenomics https://t.co/CvwRBehOl0 https://t.co/ktyxYBQezD
Cette méta analyse montre que l'#Hypertension est de loin le facteur de comorbidité le plus important chez les patients atteints de #Covid19 d'où la nécessité de trouver de nouveaux traitements comme le #Firibastat. #QuantumGenomics https://t.co/CvwRBehOl0
Tuore meta-analyysi Kiinasta (N=46,248 potilasta) osoittaa, että yksi suurimmista riskitekijöistä saada vakavampaa muotoa oleva covid-19, on korkea verenpaine. #koronavirus #koronafi #COVID19 https://t.co/DUUO1I7N0l
@RajDoctorish @tomyoung79 @trishgreenhalgh @TommyShakes @bengoldacre China: https://t.co/K3IF86nerE Italy: https://t.co/cdzn42hYoG This week the largest study (UK) suggested less risk but apparently more nuanced conclusion to come - see thread comments: h
A meta-analysis of 7 studies including 1,576 COVID-19 patients, found 21% were hypertensive, 9% had diabetes, & 8% had CD. It found that having these underlying diseases was associated with more severe COVID-19 symptoms. https://t.co/ANkTMIPQrz
RT @epibiostat: Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. -…
RT @epibiostat: Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. -…
Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. - PubMed - NCBI https://t.co/b5uakuE5cq
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis https://t.co/5ruEt4aNFk
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis https://t.co/4TL0H6Y6Oz
@SeanPlunket Okay then. Risk factors for sever patients were: hypertension, cardiovascular disease and respiratory disease. Here is a Meta Analysis from China looking at risk and covid19. https://t.co/QEn82hZ9n8
読めないけど読みたいからとりあえずメモ① 「重症度と高血圧、呼吸器疾患・循環器疾患との関連を報告したメタアナリシス論文」 Prevalence of comorbidities and its effects in patients infected with ... https://t.co/xJ6X96B0Dq
@nntaleb
@paorobgalan @RonnySuarez_ @MinSaludCol De acuerdo. Una revisión llevada a cabo en China, encontró que los pacientes con cuadros clínicos severos por COVID-19 tenían 2,3 veces más posibilidades de haber sido diagnosticados con hipertensión https://t.co/Pug
This watered down semi-real test on https://t.co/D0wbe0yhzT could be done again today. It would tell us EXACTLY who is at risk! WHY NOT THEN? B/C even that test says COMORBIDITY & AGE are likely key! #Fauci is very PRO-CHINA & outspoken till recent
They have made Americans into communist Chinese Slaves over a weak flu. So, we will end up getting implated at birth so Google who works closely with China can trace us 24/7 because of a dumbass flu! This shows my point: https://t.co/wNESN2Pkbo 2.2 milli
A partir de la información obtenida en China hasta el mes de marzo, Yang et al encontraron que había 2,3 veces más posibilidades de tener antecedentes de hipertensión arterial en pacientes con cuadros clínicos severos por COVID-19. https://t.co/PugCCT7IiC
Even this WATERED DOWN study by our OWN GOVERNMENT "The National Center for Biotechnology Information" of March 12, 2020 points at the answer. How many of you have heard anything about this - much less, with experts to explain it? https://t.co/wNESN2Pkbo
@GeneSmithSr @nypost Patients without comorbidities die from CV19. Yes, comorbidities/underlying conditions make it more likely to kill you (about 8x more likely if I'm reading right). But it can kill someone with no other known issues. Stop pretending it
Whats common between severe COVID 19 infection and Stroke? Hypertension, diabetes. Heart disease, hypercoaguability, and pulmonary disease. Continue neurochecks in your ICU. https://t.co/jCn4NZ26b5
@RealDavidOlson 3/ or numerator for that matter because of the disparity of testing- when, who, a/symptomatic, only being able to test once etc. If you hear otherwise, please share! https://t.co/hQtJOzkVOd
50% of Nepali have at least NCD (https://t.co/WHB2thRzvE). They have higher odds of getting severe COVID-19 (https://t.co/MOAaGLJfhO). Let's ensure they are not unnecessarily exposed to the virus, and get the uninterrupted continuum of care for their exist
RT @LaboratorioUa: Eight studies were included in the meta- analysis, including 46248 infected patients with #SARSCoV2 in The result showe…
Eight studies were included in the meta- analysis, including 46248 infected patients with #SARSCoV2 in The result showed the most prevalent clinical symptom was fever, and the most prevalent comorbidity was #hypertension https://t.co/7EBRBtxmfb
The most prevalent comorbidity were hypertension (17 ± 7, 95% CI 14-22%) and diabetes ( 8 ± 6, 95% CI 6-11% ), followed by cardiovascular diseases ( 5 ± 4, 95% CI 4-7% ) and respiratory system disease( 2 ± 0, 95% CI 1-3% ). https://t.co/siz6KvRyUi
@crazybalzano @AlbCantaloni Provo a mostrarti un esempio: https://t.co/lsKyyZqeNV È uno studio consolidato o no? https://t.co/FnwLlVgTtg oppure questo? Poi è chiaro che bisogna scremare. Si contagiano e muoiono persone perché purtroppo è un virus nuovo
RT @doclip1: Comorbidities and COVID Meta-analysis of n=8 studies n=46,248 infected pts : Prevalence of comorbidities: Hypertension 17%…
RT @doclip1: Comorbidities and COVID Meta-analysis of n=8 studies n=46,248 infected pts : Prevalence of comorbidities: Hypertension 17%…
Comorbidities and COVID Meta-analysis of n=8 studies n=46,248 infected pts : Prevalence of comorbidities: Hypertension 17% ,( CI 14-22%) Diabetes 8 % ( CI 6-11% ) Cardiovascular disease 5% ( CI 4-7% ) Respiratory disea…https://t.co/3m5ZHszK9Q https:/
@BeekhofGerard @rivm Dit meldt @rivm ook vandaag weer, zie https://t.co/kyc46VwFYf zie ook https://t.co/ujjib8P0ab en https://t.co/8Dizvm1XXu voor internationaal
@Trollywoodv8 https://t.co/u2LKA6HTsu Am not blaming mac. Pl go thru this. Also, I agree admk did lot of "amma nalamudan irukkirar" clown shows. But, at this time labelling the good efforts as a clown show is kind of what not acceptable to me.
Hier noch ein Preproof (elsevier), Yang et al: https://t.co/FRBAPn9IQu Damit erklärbar. Passt auf Euch auf. Meine Mutter nimmt z.B. auch Ramipril..... :-/ https://t.co/54o01sDePA
@MsEvilyne One factor against them would be higher diabetes and hypertension rates. Of course, as you say the lack of hospital beds exacerbates the situation. https://t.co/x6ci1FyyCm
@razibkhan @NeandertalGenes Forgot the link https://t.co/rKlw5auh9U
Iperensione-Diabete-Malattie cardiovascolari-Patologie respiratorie, sono in ordine di gravità le patologie concomitanti a #coronavirus che possono aggravare (più del doppio) la severità dei sintomi. FONTE: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES ht
RT @PubMedTrending: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis.…
3. Compared with the Non-severe patient, the pooled odds ratio of hypertension, respiratory system disease, cardiovascular disease in severe patients were (OR 2.36, 95% CI: 1.46-3.83), (OR 2.46, 95% CI: 1.76-3.44) and (OR 3.42, 95% CI: 1.88-6.22)respectly.
RT @COVID_Evidence: PubMed: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-…
PubMed: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis.: Related Articles Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19)… https://t.co/y2ZRunIMOs #coronavirus #
@j_foerst Maybe this helps: https://t.co/87yv8AdLlC https://t.co/oGZ5wSw1dc
Prevalencia de comorbilidades en la nueva infección por coronavirus de Wuhan (COVID-19): una revisión sistemática y un metanálisis. #coronavirus @EstebanOrtizMD Acceso AbiertoPublicado: 12 de marzo de 2020 DOI: https://t.co/oQ1I6FCZiY https://t.co/Z9DaAUI
RT @emulenews: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis https…
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis https://t.co/QT9Gj4VR2o ... entre otros metaanálisis y revisiones sistemáticas que se están publicando.
New article: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. https://t.co/RC5jzqc1vt #coronavirus #COVID19 #2019ncov
Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. https://t.co/3QlvhUVlCi https://t.co/4WQlogD9tj
We got a paper for that: «most prevalent clinical symptom was fever ( 91 ± 3, 95% CI 86-97% ), followed by cough (67 ± 7, 95% CI 59-76%), fatigue ( 51 ± 0, 95% CI 34-68% ) and dyspnea ( 30 ± 4, 95% CI 21-40%).» https://t.co/sYMqRd73ja #covid19Health4All #
#EnciérrateConLacIENCIA. https://t.co/sYMqRd73ja. «Prevalence of comorbidities »
RT @tropicafrica: prevalencia de comorbilidades en los pacientes con infección por COVID-19: enfermedad subyacente, incluida hipertensión,…
prevalencia de comorbilidades en los pacientes con infección por COVID-19: enfermedad subyacente, incluida hipertensión, enfer sist respirat y cardiovascular, puede ser factor riesgo para pacientes graves en comparación con no graves (Meta-análisis) https:
Compared with the Non-severe patient, the pooled odds ratio of hypertension, respiratory system disease, cardiovascular disease in severe patients were (OR 2.36, 95% CI: 1.46-3.83), (OR 2.46, 95% CI: 1.76-3.44) and (OR 3.42, 95% CI: 1.88-6.22) respectively